Fatal Trichoderma harzianum infection in a leukemic pediatric patient

A Serda Kantarcioğlu1, Tiraje Celkan, Ayhan Yücel

  • 1Department of Microbiology and Clinical Microbiology, Cerrahpasa Medical Faculty, Istanbul, Turkey. s.kantarcioglu@superonline.com

Medical Mycology
|January 27, 2009
PubMed

Insights

Trichoderma harzianum, a rare opportunistic pathogen, was repeatedly isolated from a pediatric patient with neutropenia. This rare fungal infection is difficult to diagnose and treat, often proving fatal.

Area of Science:

  • Mycology
  • Clinical Microbiology
  • Infectious Diseases

Background:

  • Invasive fungal infections pose a significant threat to immunocompromised patients, particularly those with hematological malignancies.
  • Diagnosing invasive fungal disease can be challenging due to difficulties in obtaining adequate samples and the patient's clinical status.

Observation:

  • Repeated isolation of Trichoderma harzianum from blood serum, skin lesions, sputum, and throat samples in a pediatric patient with acute lymphoblastic leukemia (ALL) and neutropenia.
  • The patient's poor general status and thrombocytopenia precluded invasive diagnostic procedures.

Findings:

  • Trichoderma harzianum, a rare opportunistic pathogen, was identified in multiple clinical samples.
  • This case represents the fourth reported instance of T. harzianum infection in humans, with all previously reported cases being fatal.
  • The fungus exhibited resistance to antifungal therapy.

Implications:

  • Highlights the diagnostic challenges of invasive fungal infections in immunocompromised populations.
  • Underscores the need for increased awareness and improved diagnostic strategies for rare fungal pathogens like T. harzianum.
  • Emphasizes the poor prognosis and antifungal resistance associated with T. harzianum infections.

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...